BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 6185583)

  • 1. Cytotoxic T lymphocytes reactive with vesicular stomatitis virus: analysis of specificity with monoclonal antibodies directed to the viral glycoprotein.
    Lefrancois L; Lyles DS
    J Immunol; 1983 Mar; 130(3):1408-12. PubMed ID: 6185583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic determinants of vesicular stomatitis virus: analysis with antigenic variants.
    Lefrancois L; Lyles DS
    J Immunol; 1983 Jan; 130(1):394-8. PubMed ID: 6183358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of in vitro cytotoxic T cell clones directed against vesicular stomatitis virus.
    Rosenthal KL; Oldstone MB; Hengartner H; Zinkernagel RM
    J Immunol; 1983 Jul; 131(1):475-8. PubMed ID: 6190924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
    Harris DT; Hale AH; Lefrancois L
    J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactive anti-vesicular stomatitis virus (VSV) cytotoxic T lymphocytes recognize the major surface glycoprotein.
    Hale AH; Ruebush MJ; Lefrançois L
    Eur J Immunol; 1981 May; 11(5):434-6. PubMed ID: 6266837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
    Sheil JM; Bevan MJ; Lefrancois L
    J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.
    Zinkernagel RM; Althage A; Holland J
    J Immunol; 1978 Aug; 121(2):744-8. PubMed ID: 210232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of T helper cell epitopes in the vesicular stomatitis virus: the nucleoprotein is responsible for serotype cross-reactive T help.
    Burkhart C; Freer G; Steinhoff U; Li Y; Bishop DH; Zinkernagel RM; Hengartner H
    Viral Immunol; 1994; 7(3):103-11. PubMed ID: 7541205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector.
    Keil W; Wagner RR
    Virology; 1989 Jun; 170(2):392-407. PubMed ID: 2471352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of monoclonal antibody-linked ELISA for sero-diagnosis of vesicular stomatitis virus (VSV-IN) using baculovirus expressed glycoprotein.
    Kweon CH; Kwon BJ; Kim IJ; Lee SY; Ko YJ
    J Virol Methods; 2005 Dec; 130(1-2):7-14. PubMed ID: 16076499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An enzyme-linked immunosorbent assay for the detection of bovine antibodies to vesicular stomatitis virus.
    Workman T; Shen D; Woodard L; Yilma T
    Am J Vet Res; 1986 Jul; 47(7):1507-12. PubMed ID: 3017162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo.
    Lefrancois L
    J Virol; 1984 Jul; 51(1):208-14. PubMed ID: 6328040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host.
    Martinez I; Barrera JC; Rodriguez LL; Wertz GW
    Vaccine; 2004 Sep; 22(29-30):4035-43. PubMed ID: 15364454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against the two serotypes of vesicular stomatitis virus measured by enzyme-linked immunosorbent assay: immunodominance of serotype-specific determinants and induction of asymmetrically cross-reactive antibodies.
    Charan S; Hengartner H; Zinkernagel RM
    J Virol; 1987 Aug; 61(8):2509-14. PubMed ID: 2439706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial immunoglobulin light chain variability creates sufficient B cell diversity to mount protective antibody responses against pathogen infections.
    Senn BM; López-Macías C; Kalinke U; Lamarre A; Isibasi A; Zinkernagel RM; Hengartner H
    Eur J Immunol; 2003 Apr; 33(4):950-61. PubMed ID: 12672061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common distribution of antigenic determinants and complementation activity on matrix proteins of two vesicular stomatitis virus serotypes.
    Sun W; Huang L; Wagner RR
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():937-43. PubMed ID: 7512123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.
    Lefrancois L; Lyles DS
    Virology; 1982 Aug; 121(1):157-67. PubMed ID: 18638751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of DNA-mediated gene transfer to analyze the role of H-2Ld in controlling the specificity of anti-vesicular stomatitis virus cytotoxic T cells.
    Forman J; Goodenow RS; Hood L; Ciavarra R
    J Exp Med; 1983 Apr; 157(4):1261-72. PubMed ID: 6187888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human lymphocyte function associated antigen-1 (LFA-1): identification of multiple antigenic epitopes and their relationship to CTL-mediated cytotoxicity.
    Ware CF; Sanchez-Madrid F; Krensky AM; Burakoff SJ; Strominger JL; Springer TA
    J Immunol; 1983 Sep; 131(3):1182-8. PubMed ID: 6193178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.